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Abstract
Background: In most countries, the numbers of work-related cancer identified are much lower than are the
estimated total burden of cancer caused by exposure at work. Therefore, there is a great need to use all available
practical as well as epidemiological methods for identification as well as to develop new methods of recognizing
cases of work-related cancers.
Methods: Primarily based on practical experiences from Norway, methods to identify cases of possible work-
related cancers in the general population and at workplaces as well as methods to recognize more specific cases
after referral to specialized clinics are reviewed in this publication.
Results: Countries applying a number of the available methods to detect work-related cancer reach a reporting
rate of 60 such cases per million, while other countries that do not employ such methods hardly identify any
cases. As most subjects previously exposed to cancer causing agents and substances at work are gradually
recruited out of work, methods should be versatile for identification of cases in the general population, as well as
at work.
Conclusions: Even in countries using a number of the available methods for identification, only a limited fraction
of the real number of work-related cancer are notified to the labour inspectorate. Clinicians should be familiar with
the methods and do the best to identify work-related cancer to serve prevention.
Background
A number of estimates on the contribution from work
exposure to the total burden of cancers in the world, as
well as for specific countries, have been presented; the
estimates vary from 2-3% to 6-7% [1-3]. Although these
estimates vary greatly and no data are available from
developing countries, we assume that the contribution
by weight is about 5%. This gives an approximate num-
ber of yearly new weighed cancer cases (total burden)
that are related to work exposure, for example, in Tai-
wan, of about 3,500-4,000 out of about 75,000 newly
registered cases per year. As “total burden” means 100%
contribution on case basis, and hardly any case is 100%
caused by work exposure, the total number of new cases
with causal contribution from work exposure is much
higher. However, the fact remains that only a handful
cases are recognized as work-related cancer in Taiwan.
Even in Western countries, for example, in Norway -
with a total population of about 4.9 million and with
about 80-years practice of identifying work-related dis-
eases, including cancers - only about 300 cases of “sus-
pected” work-related cancers are notified yearly to the
work inspectorate. Assuming that 5% of the total burden
of cancer is attributable from work-related exposures
also in Norway, some 1,200-1,300 cases per year are due
to work - out of about 25,000 incident cases. Underre-
porting is an obvious problem, even in developed coun-
tries like Norway, only about one-fourth of the total
burden (300 out of 1,200) could have been reported as
suspected cases. Currently, a smaller number, close to
200 (60~70%) out of the reported cases, are recognized
by the Norwegian National Insurance Scheme (NIS) and
private insurance companies as work-related to an
extent that meets the requirements to be compensated
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reported cases is increasing, and since there is a delay in
the handling of such cases by NIS, the real proportion
of compensated cases may be a little higher.
A significant number of cancer cases are identified as
work-related in most Western countries, Australia,
Japan, Singapore and South Africa, but these numbers
are far below the estimated real figures, as based on
about 5% of the total cancer burden. In developing
countries, only a few cases are reported each year. In
countries like Thailand and Malaysia only a handful of
mesotheliomas have been identified, and in Taiwan, less
than 10 cases of mesothelioma (387 cases from 1979 to
2005 based on Taiwan Cancer Registry) have been
authorized as occupational cancer [4]. Hardly any case
of work-related cancer is identified and recognized in
some developing countries.
The aim of this publication is to review methods
applied in different countries to identify cases of possi-
ble work-related cancers in the general population and
at workplaces, as well as methods to recognize more
specific cases after referral to specialized clinics. Even in
countries that apply a number of the methods for iden-
tification listed below, the rate of identification of cases
reaches only a fraction of the estimated total number of
work-related cases. Still, countries applying one, two or
more of the available methods, appear to be more suc-
cessful than are countries not applying any methods to
identify cases. In this paper examples from Norway are
used to the extent that they may be assume to help
enhance detection and recognition of work-related can-
cers in other countries.
Methods
Some of the methods listed below may identify work-
related cases directly, while others may be considered as
tools for identifying the presence of work-related can-
cers in the general populations at large or in small
populations exposed to specific or possible carcinogenic
agents, substances or compounds.
I. Population-based methods to identify work- and
environment-related cancers
a. Gender differences
Many countries have developed high quality cancer reg-
isters and/or mortality data, which may serve as tools to
identify gender differences in the incidence or mortality
rates for cancer locations common to the genders. In-
depth analyses or epidemiological research of site speci-
fic cancers that occur with a higher incidence/mortality
rate in males than in females can generally provide
information as to why these differences occur. In the
1970’s, male cancers of the nasal sinuses occurred with
nine times higher incidence than in females in one
Norwegian province [5]. The cause appeared to be that
some 1,500 males in the province worked in a nickel
refinery.
As for lung cancer, Finland may be an excellent exam-
ple on male/female differences, with a very low incidence
among females particularly in the 1950’s - possibly close
to the assumed archaic risk level for both genders - but
also an unusually high incidence among men in the
1970’s [6]. Although smoking is undoubtedly the most
significant determinant for lung cancer in males in many
countries, exposure at work may contribute about 15% of
the cases by attribution in some countries [7].
b. Regional differences in the incidence or mortality
All countries with high quality data on cancer incidence
and/or mortality may identify at least two-fold, and in
some instances four- to six-fold, incidence/mortality for
some cancer sites - in high risk versus low risk areas.
For cancer sites with high rates of long-term survival,
incidence data are more versatile for this purpose than
are mortality data. Clearly, given that the figures are
robust, such large differences cannot be explained by
differences in the genetic shape or susceptibility.
In Norway two- to six-fold regional differences are
observed for many cancer sites, i.e. for stomach cancer,
cancer of the thyroid gland, malignant melanomas of
the skin, and even for lung cancers [8]. Some of these
large differences may be due to local causative factors,
i.e. at a given factory or workplace where subjects
have been exposed to given carcinogens. As mentioned
before, such an example was observed in Norway in the
1960’s and 1970’s, where male cancer of the nasal
sinuses was up to nine times higher in one province
than in others, probably due to occupational exposure
to nickel compounds in a nickel refinery [5].
Exposure factors in the general environment may also
cause significant differences in the incidence of given
cancer sites, e.g. regional differences for oral cancer in
Taiwan, an endemic betel quid chewing area [9,10].
Some heavy metals contaminated in the soil might pro-
mote oral cancer development in local residents [11].
c. Epidemiological studies on work-related cancers
Whenever large differences in incidence or mortality are
observed, one should initiate appropriate epidemiological
studies among the general population of the areas/muni-
cipalities that present high incidence or mortality of site-
specific cancer, in order to identify work-related contri-
butions to the differences. In some instances one may
already have a hunch as to what the possible causation is,
e.g. given workplaces in the region. If that is the case, it
may be more versatile to carry out epidemiological stu-
dies among the known exposed population, thus identify-
ing accurately - for previous and current workers - their
previous exposure in that workplace and previous
workplace(s), subsequently carrying out a historical,
Langård and Lee Journal of Occupational Medicine and Toxicology 2011, 6:24
http://www.occup-med.com/content/6/1/24
Page 2 of 10prospective cohort study. Having identified that cohort
and the participant’s exposures, linkage to cancer inci-
dence or mortality data may be carried out. A major site
of environmental pollution may also be the cause of local
enhancements of cancer incidence/mortality.
In Norway, only a handful of work-related cancers
were reported to the work inspectorate in the 1950’s
and 1960’s. It was only after epidemiological studies on
work-related cancers were performed from the early
1970’s [12,13] and onwards, that physicians, workers,
worker’s unions, and also the news media and the pub-
lic, began paying attention to the carcinogenic hazards
in workplaces. Once these first studies were published, a
wave of new cancer-studies in different industries and
workplaces were initiated and carried out during the
second half of the 1970’s and the early 1980’s [14-19].
Once the results from the different studies had been
presented to the workers involved, and subsequently
appeared in the scientific journals, an increasing number
of suspected cases of work-related cancer were identified
and reported by physicians to the work inspectorate as
well as being referred to the clinical departments of
occupational medicine. While presenting this informa-
tion to workers, the physician scientists also frequently
appeared in the mass media to inform the public about
work-related cancers. More frequent referral of patients
to the clinical departments clearly appeared to be
related to the awareness about work-related cancer
among the physicians in the country.
Thus, irrespective of local or regional differences in
the incidence or mortality for specific cancer sites in the
general population, epidemiological studies on the inci-
dence or mortality of cancer should be carried out
among industrial workers and also among workers of
other workplaces whenever there is science-based indi-
cation of an existing carcinogenic hazard in a workplace.
The experience from the Nordic countries clearly shows
that performing cancer studies among workers exposed
to carcinogenic agents or compounds strongly enhances
the awareness in work-related cancers among medical
professionals and workers.
d. Specialized clinical departments for work-related diseases
The establishment of specialized hospital-based depart-
ments/clinics for occupational medicine was initiated in
Norway as of 1977. Subsequently, five more clinics were
established during the second half of the 1980’sa n d
early 1990’s. Later, two clinics have merged, thus leaving
five clinics for occupational and environmental medicine
in Norway today. Only a few cases of work-related can-
cer were identified before these departments were estab-
lished. These clinics also have carried out many studies
on work-related cancer.
Research activities, as well as the clinical work carried
out by these clinics, have contributed to enhancement
of regional interest on work-related cancers/diseases,
particularly among primary health care physicians and
occupational health physicians. The awareness among
these primary health physicians on cancers possibly
being work-related strongly depends on their relevant
education. Primary health physicians’ education on
work-related cancers/diseases relies on the following
fundamental factors:
a) their primary education in medical school; and
b) continuous updating/courses during the physician’s
whole career, to retain and enhance their knowledge on
as well as alertness of identifying work-related cancers/
diseases.
One of the major tasks of these clinical departments is
to facilitate education on work-related cancers/diseases
among primary health care doctors as well as occupa-
tional health physicians, e.g. by arranging relevant
courses as well as lectures among colleagues. The clini-
cal departments also have succeeded in gently “infiltrat-
ing” other specialty courses with lectures on the
occurrence of and necessity of awareness of work-
related cancers/diseases. In Norway, attempts to intro-
duce occupational medicine beyond basic education in
the curriculum of the medical schools have generally
been less successful. However, medical schools of the
other Nordic countries have been more willing to widen
the scope of education on occupational medicine and
on work-related cancer in medical schools.
Also, regional and national education of physicians on
this field has contributed to enhancement of the aware-
ness among workers that their cancer/illness may be
related to work exposure. The clinical departments have
also facilitated awareness among the workers that new
cases of cancer may be work-related, and have been
active in informing the public and workers on the
results of cancer studies and the possibilities of work-
related cancers. Worker’s unions may to a great extent
support enhancement of the awareness among workers
that some cancer cases may be caused by exposure
at work.
e. Obligatory reporting by all physicians on suspected cases
Physicians must file reports on suspected cases of work-
related cancer to the work inspectorate in some countries
whenever the physician suspects that the disease may be
related to work exposure. In Norway, notification on
work-related diseases started in 1933 and primarily to
report cases of silicosis to the work inspectorate, which
had a high incidence in the 1930’s [20]. The primary pur-
pose of this reporting system was to enhance prevention
by notifying the work inspectorate on hazardous work-
places that might cause occupational diseases, thus giving
the inspectorate the opportunity to visit the worksites of
concern and to subsequently communicate measures to
the employers and employees on preventive strategies.
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work-related cancers/diseases, should be characterized
by “low threshold”.T h er e p o r t i n gf o r mm u s tb es i m p l e
in order to ensure a low threshold. The physician should
only be required to provide the patient’s identity, sus-
pected relevant exposure, the identity of the employer
where the suspected exposure took place, and the physi-
cian’s judgment as to possible work-relatedness. The
physician should not be required to attempt to “prove”
that the cancer/disease is work-related. The reporting
should only be based on suspicion of work-relatedness.
Reporting on “suspected” work-related cancers/diseases
should be obligatory, thus avoiding concerns that the
physician filing a report on work-related cancer could
be accused of trying to hurt the workplace of concern.
In Norway only a handful of work-related cancers, e.g.
a few mesotheliomas and nickel-related cancers, were
notified to the labor inspectorate prior to the 1970’s.
Without the legislative support to make report filing
obligatory, lawsuit could hypothetically be filed against
the physician for trying to hurt a workplace. There
should also be a reward to the physician for reporting,
corresponding to the average time she/he spends on
compiling necessary information on exposure, filling the
form and filing the report. Informed consent should be
obtained prior to filing report.
Once the report form is filed, it must be up to the
labor inspectorate, the insurance scheme and/or specia-
lists in occupational medicine, to clarify the work-relat-
edness of the cancer case or disease and to determine to
what extent the case is work-related.
To motivate report filling, it is of major importance
that the physician receives feedback that reporting cases
serves prevention and also may have positive conse-
quences for the patients. The feedback system must
make it clear to the physicians that reporting is of great
significance for both aspects. Today, an online system
for reporting and feedback can easily be introduced on
the statistics of such reports, the uses of the filed reports
for prevention, and the patient benefits of the reports.
Such feedback appears to enhance the number of filed
reports.
There are, however, still major deficiencies in filing
reports on work-related cancer also in many Western
countries, e.g. many physicians are not filing reports,
indicating a significant potential for improvements in
the reporting system. With obligatory reporting, there
may be a potential that a physician failing to file a
report an obvious case of work-related cancer could be
accused of malpractice for not reporting relevant cases.
In the mid 1980’s an alteration was made in the filing
system in Norway; an additional copy of the reporting
form was to be filed to the National Insurance Scheme
(NIS), leaving the responsibility for case follow-up to the
insurance scheme, e.g. to refer the case subject to a clin-
ical department of occupational and environmental
medicine to have the work-relatedness scrutinized.
Based on a comprehensive identification and quantifica-
tion of previous exposure, as well as consulting relevant
scientific literature, the department physician subse-
quently files an expert statement to the insurance
scheme. This statement serves as basis for judging
work-relatedness for the insurance, which makes the
decision on whether or not the exposure and the disease
justifies acceptance as occupational disease/cancer, in
accord with current legislation.
As of today about 300 cases of cancer are reported
yearly to the labor inspectorate in Norway, of which
about two thirds are cancers of the airways - including
mesotheliomas.
f. Tool for detection of cases based on cancer or mortality
registers
Resulting from an incident in the mid 1980’s, in which
the “Data inspectorate” - referring to patients’ confiden-
tiality - denied filing reports on work-related cancers for
deceased subjects that had been identified in an epide-
miological study [21]. As it was felt to be inappropriate
that some cancer case subjects in a given cohort could
be scrutinized for possible compensation for occupa-
tional cancer, while others were denied such scrutiny, a
letter was drafted to - with permission from the Data
inspectorate - be sent from the Cancer Registry to
patients with certain cancer diagnoses, known frequently
to be work-related. To select case subjects to receive
such a letter, the case subject was linked to two or three
censuses, which contain information on occupations.
The patients to receive the letter are those who have
one of those cancer diagnoses and certain high-risk job
titles - over two or three consecutive censuses - that are
known to carry an elevated risk of work-related cancers.
The letter informs the patient that his/her cancer might
be work-related, and suggests referral by the primary
physician to a clinical department of occupational and
environmental medicine to for scrutiny on possible
work-relatedness. Currently such letters are submitted
to patients in some countries, e.g. Norway and Canada.
g. Educating colleagues with specialties frequently
encountering cases of work-related cancers
As a large proportion of the known work-related cancers
occur in the respiratory organs, there should be ways to
enhance the awareness of the presence of work-related
cancer among specialists frequently encountering nasal
sinus cancers, mesotheliomas, and different types of lung
cancers. A method for asbestos-related cancers is simply
to convince pulmonologists, radiologists, internists, and
pathologists to refer all cases u b j e c t sw i t hb o t hl u n g
cancer and typical asbestos-related pleural plaques or
calcifications to the departments of occupational and
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malignant mesotheliomas, of which nearly 95% has been
attributable to previous exposure to asbestos fibers [2].
Furthermore, case subjects with typical asbestos-asso-
ciated pleural plaques and a cancer of other organs gen-
erally known be related to past exposure to asbestos, e.g.
cancer of the oesophagus, colon and rectums, as well as
of the kidneys and the urinary bladder [22-24], should be
referred for scrutiny on work-relatedness.
h. Screening the general population by questionnaires
Workers previously exposed to asbestos fibres and other
carcinogenic agents or compounds in workplaces even-
tually end up in the general population. Consequently,
most subjects previously exposed to work-related carci-
nogenic factors are found in the general population.
Identification of these previously exposed subjects can
be accomplished by designing questionnaires to be sub-
mitted to certain age groups, e.g. preferably males aged
40 years and above or more than 50 years. This transfer
of disease risks from the workplace to the general popu-
lation has been particularly strong for the subjects pre-
viously exposed to asbestos for which the seized use of
asbestos over the past 3 decades has enhanced the
transfer of asbestos-exposed subjects at the work site to
the general population. Consequently, questionnaires
designed to identify previous workplaces and work-
related exposure to asbestos, should be designed for
screening of the general populations. To account for
latency, questions should be developed specifically to
identify previous asbestos-exposure in the industry/
workplaces of the region more than 20 years ago.
Such population-based exposure screening might be
combined with various other types of screening instru-
ments, specifically designed to identify certain cancers
or exposure markers. In the early 1980’s, a large scale
screening in which 21,453 males, aged 40 years and
above, were screened by questionnaires and lung X-rays
was carried out in Norway, indicating that population-
based screening was indeed efficient [25]. 3,888 were
confirmed exposed and 2,820 had uncertain exposure to
asbestos, of whom 470 (2.2%) had asbestos-related lung
disorders, including 86 parenchymal asbestoses. Ques-
tionnaire screening, possibly combined with lung X-rays,
could be carried out in the neighborhoods of previous
work sites with a known high probability of exposure to
asbestos or other carcinogenic agents.
II. Clinical methods to recognize work- and environment-
related cancers
Some cancer cases are easily recognized as work-related,
e.g. near 95% of malignant mesothelioma cases are
caused by exposure to asbestos [2]. Close to all 60-65
yearly new male cases [8] in Norway occur in the pre-
viously asbestos-exposed subjects [7]. Therefore, once
exposure to asbestos is documented in cases of malig-
nant mesothelioma,t h ei n s u r a n c es c h e m ea c c e p t st h e
cases of malignant mesothelioma as being subject to
compensation.
Except for some exposure factors with a skewed distri-
bution towards a given histological type, e.g. adenocarci-
noma of the lung after asbestos exposure [26], work-
related cancers are histologically not distinguishable
from non-work-related cases. Thus, distinguishing a
work-related cancer case from a non work-related case
can only be accomplished through a very comprehensive
exposure history.
a. Work- and exposure history
T h eo n l yw a yt oi d e n t i f yt h ep o s s i b l ec a u s e so fag i v e n
case of cancer is to identify and to (semi)quantify work-
and environmental exposure in the past, preferably from
the conception onwards - up to the day the case subject
is referred for causality determination. Recognition of
work-relatedness of cases is fully dependent on a com-
prehensive and precise life-long exposure history, docu-
menting all relevant exposure factors during all periods
of previous work, subsequently (semi)quantifying all the
exposures that possibly may have contributed to
increased risk of the cancer cases of concern.
Work- and exposure history It is recommended to
separate the anamnesis in a section for chronological
employment work history and one for specific exposure
during each employment period.
The general employment history should contain dates
for start and for quitting for each consecutive job.
The section for specific exposure should identify all
exposure factors as far as possible in order to quan-
tify both levels of exposure and the duration of
exposure to each significant exposure factors during
every employment period.
As example, if a patient had welded in a shipyard
from February 1, 1959 until December 31, 1968,
information on the main types of welding that he
carried out should be identified specifically as well as
the duration of each type of welding operation, the
extent to which he welded in confined spaces and
the extent to which he welded in the work-shop, the
types of steel that he welded, the types of electrodes
he used in each operation, the extent to which there
were other welders in the neighborhood, if there was
ongoing concomitant insulation (asbestos), the
extent to which he use certain kinds of respirators,
and finally - the extent to which there were other
possible exposures, i.e. soldering.
Furthermore, it should be determined whether or not
the data from environmental monitoring relevant for the
patient is available for his workplaces and whether or
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work hours were distributed between each of the differ-
ent tasks should also be recorded. Moreover, the size
and space of the work facility in which the employee
worked and the possibility of additional bystander expo-
sure should be considered. Extended periods of absence
from work should also be registered. A description of
the facility and the presence of general and/or local ven-
tilation should be taken into account.
Some countries have compiled measurements in
industries in national databases for current and histori-
cal measurements on exposure in its workplaces, which
is a useful source of information on levels of exposure.
The databases may contain measurements in the work-
place of concern or in comparable workplaces from the
same time period.
When the work/exposure history is completed, the
information on the subject’s exposure to various sub-
stances, dusts, agents, or substances, must be in depth,
thus permitting judgment - preferably quantification - as
to the subject’s exposure-related current and projected
(future) added risk of one or a number of cancers. (See
below on reference articles).
Significance of the “latent period” Due to the long
latent period - generally defined as the time period
between the first exposure to the causative agent/com-
pound and the occurrence/diagnosis of the disease - for
most work-related cancers, exposure in early life and
early work periods are more likely to have contributed
as a cause for the disease than exposure late in the work
period. Consequently, it is of major importance to com-
pile an accurate exposure history for the early employ-
ment periods. Therefore, when searching either cohort-
or case-referent scientific articles for reference, one
should search for publications that account for latency
or that present the data in a way that permits physicians
to apply the dose-response data and account for latency
at the same time.
Reference articles High quality scientific articles that
present robust results and deal with exposure and can-
cer outcome closely matching those of the case subjects,
are obligatory in order to estimate and/or judge the
(semi-)quantitative risk of cancer in the case patient
prior to occurrence of the disease. Reference articles
that closely match the patient’se x p o s u r ea sw e l la st h e
cancer site should be preferred. Articles that report on
data from a well designed and properly performed epi-
demiological studies, also presenting dose-response rela-
tionships for the exposure-factor(s) and the cancer
outcome of concern, should also be preferred. To be
applicable, the dose-response scale presented in the
publication should include the patient’s exposure level
in terms of intensity and duration, preferably during a
time period that adheres to the experienced “latency”
period for the cancer of concern.
Such reference articles could preferably be common to
all the medical professionals who work in a clinical
department of occupational and environmental medi-
cine. The articles may prove versatile to permit indivi-
dual assessment of disease risk(s). There could be
common or “standard” reference articles for the most
frequent cause/effect relationships that the department
is scrutinizing. These reference articles should be
updated as soon as new and possibly more representa-
tive articles are published.
In addition to sets of common reference articles on
frequently encountered possible causal relationships,
additional literature should be reviewed for individual
patients in order to find published exposure situations
that match the patient’s exposure and disease even bet-
ter than the cases that can be found in the sets of com-
mon reference articles.
Other contributing causes O n c eac o m p l e t ee x p o s u r e
history on relevant work- and environment-related
exposures has been compiled for the patient, one is in
the position to account for these exposures such as
cigarette smoking, use of ethanol, passive smoking dur-
ing childhood, at work and at home, exposure to radon
daughters at work or at home, and other possible com-
peting causes of the disease case.
Quantifying individual disease risks By compiling
comprehensive information on all the past significant
exposure factors, that are known to carry an intrinsic
potential to increase individual risks of cancers or other
diseases, it may be possible to quantify the subject’sr i s k
of the cancer or disease of concern as well as for other
cancers, prior to occurrence/detection of the case. Based
on the compiled exposure-information, the subjects’
individual - current and projected - levels of risks for
different cancers can be estimated by consulting robust
scientific literature that represents dose-response data
for the exposure-factor(s) of the patient. Based on the
subjects’ exposure, current and projected cancer and
disease risks may be derived from the dose-response
i n f o r m a t i o ni ns u c hh i g hq u a lity epidemiological data.
Accumulated cancer/disease-risk related to the most sig-
nificant disease determinants of a subject does not tell
anything about causation as defined by Rothman et al
[27]. However, until real quantitative measures of con-
tributory cause are developed, accumulated exposure-
related risk may possibly serve as a surrogate for causal
contribution.
Sufficient exposure Whenever all the above information
on exposure is compiled - which is necessary in order
to judge an individual case of cancer for work-related-
ness - one has to judge whether the prime exposure
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contributes sufficient exposure to increase the risk of
cancer sufficiently to be considered to have caused the
case - alone or in combination with the other work- or
non-work-related exposure factors. Whether or not suf-
ficient exposure might be considered to have accumu-
lated during a relevant time period should be based on
dose-response data in representative scientific literature.
Experienced or assumed latent period - as based on data
from the scientific literature - also has to be accounted
for in this judgment, e.g. 15-25 years or more, depend-
ing on which cancer has occurred, the intensity of expo-
sure, and the potency of the causal factors(s).
Doubling of the risk could serve as criterion of insur-
ance companies for accepting a cancer case as an occu-
pational disease. The degree of increased association
with a specific exposure is determined usually with mea-
sures such as relative risk or absolute risk. Basically the
stronger the association, the less likely it is due to error.
National insurance schemes and insurance companies in
some countries apply the notion “doubling of the risk”
for a given case of exposure-related cancer as a basis for
accepting the case as work-related, hence for compen-
sating the cancer as occupational disease. Many weak-
nesses of the notion doubling of the risk were discussed
in depth by Greenland [28] and Morfeld [29]. In this
paper we add another weakness by pointing to the lack
of defining what doubling of the risk is based on, i.e.
what is the reference for doubling. When no level of
risk is defined to serve as basis for doubling, the notion
is non-informative, hence a “floating unity” (Figure 1).
Therefore, to avoid the problem of referring to doubling
of the risk in expert-statements to an insurance schemes
o rc o m p a n i e s ,o n es h o u l dp r e f e r a b l yp r e s e n tt h ee s t i -
mated áp r i o r iabsolute risk of the patient prior to the
occurrence of the disease, along with the risk for two
different reference populations;
a) the absolute risk in age- and gender-specific risk
of the general population, and
b) the presumed archaic risk of the cancer or disease
that corresponds to the subject’s age/gender.
A na p p r o x i m a t ea r c h a i cr i s km a yb ee s t i m a t e df o ra
number of cancer sites, i.e. lung cancer in Finland -
w h e r et h ei n c i d e n c ei nw o m e ni nt h e1 9 5 0w a sa b o u t2
cases per 100,000 per year [6]. The use of these two
alternative entities as reference may result in differences
in the attribution to different causes. If one is not in the
position to present both these two sets of preferred
reference-risks, the assumed most appropriate level of
reference risk should be identified and also defining this
risk level in absolute terms.
Some insurance schemes or insurance companies may
demand estimates of the weighted attribution to differ-
ent contributing exposure factors. Such attribution - or
partition - of weighted causality to the identified causal
factors could be based on comparison of the cumulated
exposure-related risks of the cancer of concern, resulting
from exposure to different exposure factors. Attributed
weighted contribution to the different identified causal
factors could be based on the risk of the cancer of con-
cern that has been accumulated resulting from each
individual exposure factor prior to occurrence of the
cancer case [7]. To permit such an estimate, cumulative
exposure to the causal factors in relevant time windows
must be accurately compiled in order to permit compar-
ison with dose-response data on the association of con-
cern acquired from one or more robust, well designed
and performed epidemiological study/ies. To allow cal-
culation of cumulated relative or absolute risk of the
cancer of concern in the case subject, the level of abso-
lute risk of the reference population must be identified
[23].
As criteria are not defined for the terms “robust and
well designed” reference studies, these terms may be
ambiguous. Robustness implies adequate power of the
study and well designed implies that exposure to all sig-
nificant exposure factors have been compiled at least for
the majority of the participants - preferably for nearly
the whole study population - permitting analysis of
synergetic effects as well as statistical interactions in
accord with suggestions by Greenland et al [30].
No comparison can be made of the patient’s áp r i o r i
cancer risk to the “background” risk (reference risk) if
the reference risk is undefined. One possible reference
risk is that of the gender and age adjusted general popu-
lation. Another reference risk could be the archaic risk
of cancer, e.g. the estimated or assumed age and gen-
der-adjusted risk of cancer in the (hypothetical) absence
of all cancer causing factors in the environment and at
work. The archaic risk is not known for many cancer
sites, but can be estimated by consulting the lowest ever
incidence of a specific site in countries with high quality
incidence data.
As tobacco smoking is a strong determinant of many
different cancers, in particular for cancer of the respira-
tory organs, smoking is frequently a competing cause
for cases of cancer that are partially caused by exposure
at work. As lung cancer is the cancer site with highest
incidence of work-relatedness in the Western world,
and asbestos is the work-related cause with the highest
incidence, asbestos exposure and tobacco smoking are
commonly combined causes of lung cancer cases.
Hence, if the insurance company/scheme asks for
weighed attribution to the cancer case by smoking and
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the following suggestion [31].
Discussion
Expert statements on work-relatedness should consider
solely whether or not - and to what extent - the expo-
sure(s) of concern is/are likely cause(s) of the cancer/dis-
ease. The statement should be based on robust scientific
literature that reflects the exposure of the case subject as
closely as possible, which is aimed at in Norway. Based
on long term experience from clinical handling of case
subjects, we advice that expert statements should prefer-
ably be based exclusively on scientific evidence. However,
as robust scientific literature that represents the exposure
and the disease of the subject is not always available, the
medical expert may be left with an absence of relevant
reference literature, leaving sound judgment based on
experience as the only option. Whenever that is the situa-
tion, the expert should not attempt to provide science-
based responses to the insurance scheme/company’s spe-
cific questions, because that is impossible. Instead, the
expert should clearly state that no relevant scientific lit-
erature is available to support a science-based statement.
She/he could also state specifically the level of confidence
in her/his responds to the different questions.
Whether a cancer case or disease is to be considered
as an “occupational disease”, hence to be compensated,
i sn o tt ob ej u d g e db yt h em e d i c a le x p e r tf i l i n ga
science-based statement to an insurance scheme or
company. That decision should exclusively be taken on
the basis of the rules for decision-making to which the
insurance scheme or company must adhere. The insur-
ance scheme/company is likely to ask questions on caus-
ality and possibly on weighed attribution in order to get
science-based answers that may meet their needs, per-
mitting judgment on the basis of their roles for accep-
tance as “occupational disease”.
If the rules for acceptance of the insurance scheme or
company consider doubling of the risk as sufficient
enough to judge the case as occupational cancer/disease,
one should attempt to clarify the weaknesses of that
notion, as suggested above. One should show how “dou-
bling” gives different results for attribution depending
on which reference level that is used.
No one is able to tell which factor that initiated the
development of a given case of cancer whenever the case
Figure 1 Identify doubling of the risk for lung cancer. Insurance schemes and companies in some countries apply the notion “doubling of
the risk” of a given case of exposure-related cancer as criterion to compensate work-related cancers. Any population may comprise a number of
subpopulations with cancer risk related to a number of exposure factors as illustrated. As illustrated, a study may have identified just in excess of
doubling of the lung cancer risk in a small sub-population of those exposed to nickel compounds when referring to the age-adjusted general
male population. Had the archaic risk, here presumed to be at 0,2 compared to 1,0 for the general population, the relative risk (RR) in the
same sub-population of the nickel-exposed would have been at more than 10,0 in the reference level. Which background risk should serve as
reference for “doubling"?.
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may have initiated the cancer. Thus, it might be argued
that attribution of relative weight of causation on the
basis of relative level of estimated cancer risk prior to
o c c u r r e n c eo ft h ec a n c e rm a yn o tb em o r ea p p r o p r i a t e
than just guessing the contribution from each causative
factor. On the other hand, when having applied this
method in, e.g. 100 similar cases, one may be quite sure
that the average outcome result becomes much closer to
the true weights of attributed causation than the use of
other methods of attribution can demonstrate. The
method [31] also permits to account for synergetic inter-
actions, e.g. enabling attribution of the interaction effects
of smoking and asbestos in the development of lung can-
cers. Also, whenever the contribution by asbestos to the
total cancer risk is relatively high in a given case, attribu-
tion of the outcome contribution resulting from the á
priori risk from the effect of interaction in proportion to
the relative risk contribution of each of the two factors,
the attribution to asbestos frequently becomes higher
than when applying the notion “doubling of the risk” as
criterion for acceptance as “occupational disease”.
Another consequence of attribution in accord with the
áp r i o r iexposure-related risk is that, whenever the case
subject who has contracted lung cancer - receives full
workers’ compensation on the basis of doubling or more
of the lung cancer risk related to exposure to asbestos,
it may become difficult to seek alternative compensation
for other causative factors which might have elevated
the a priori risk 10-20 times above the same background
level, i.e. tobacco smoking.
Conclusions
Although it seems unlikely ever to accomplish complete
identification and reporting of work-related cancers,
even when applying all available methods of identifica-
tion, countries applying these methods, e.g. Norway, can
demonstrate a much higher rate of identification of
cases than countries not using the methods. Also, a
country like Japan, which identified only 50-60 yearly
cases of work-related cancer up to 5-6 years ago, and
has currently increased that number to 2-3,000 over the
last few years due to asbestos-associated cancers [32].
The figures for increased rate of detection in Japan
clearly shows that other countries in Asia have a huge
potential of identifying large numbers of work-related
cancers, hence hopefully giving them the ability to pre-
vent such cancer cases in the future.
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